CN104287046B - 一种以花生为主要原料的生物型饮料 - Google Patents
一种以花生为主要原料的生物型饮料 Download PDFInfo
- Publication number
- CN104287046B CN104287046B CN201410624518.2A CN201410624518A CN104287046B CN 104287046 B CN104287046 B CN 104287046B CN 201410624518 A CN201410624518 A CN 201410624518A CN 104287046 B CN104287046 B CN 104287046B
- Authority
- CN
- China
- Prior art keywords
- peanut
- raw material
- beverage
- tea
- juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000010777 Arachis hypogaea Nutrition 0.000 title claims abstract description 103
- 235000017060 Arachis glabrata Nutrition 0.000 title claims abstract description 102
- 235000018262 Arachis monticola Nutrition 0.000 title claims abstract description 102
- 235000020232 peanut Nutrition 0.000 title claims abstract description 102
- 239000002994 raw material Substances 0.000 title claims abstract description 33
- 235000013361 beverage Nutrition 0.000 title claims abstract description 25
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical compound CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 241001553178 Arachis glabrata Species 0.000 title 1
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 103
- 235000019225 fermented tea Nutrition 0.000 claims abstract description 36
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 25
- 241000894006 Bacteria Species 0.000 claims abstract description 15
- 244000269722 Thea sinensis Species 0.000 claims abstract description 14
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 11
- 235000020279 black tea Nutrition 0.000 claims abstract description 11
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002002 slurry Substances 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 3
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 238000010564 aerobic fermentation Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000013021 overheating Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 8
- 235000013616 tea Nutrition 0.000 abstract description 8
- 241000233866 Fungi Species 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 4
- 208000034189 Sclerosis Diseases 0.000 description 4
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 235000021283 resveratrol Nutrition 0.000 description 4
- 229940016667 resveratrol Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 241000235342 Saccharomycetes Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000019395 Lactation disease Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 206010042576 Suppressed lactation Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000031169 hemorrhagic disease Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241001061106 Sargocentron rubrum Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012627 chemopreventive agent Substances 0.000 description 1
- 229940124443 chemopreventive agent Drugs 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020542 functional tea Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000020265 peanut milk Nutrition 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
一种以花生为主要原料的生物型饮料，是以花生粒为主要原料制备花生浆汁，然后再以花生浆汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出新型特色的花生红茶菌饮料。通过实施本发明，将花生和红茶菌有机结合起来，所组合起来的营养物质更加丰富；花生和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，形成的茶饮料保健功效更为彰显，其综合效果远超单纯花生制成的食品及传统的红茶菌饮料。同时，制备出来的花生红茶菌饮料产品形态理想，产品很好地保留了花生原有的营养和功能成分，容易消化吸收，口感酸甜适口，适口性非常好，适用人群极为广泛，是一种兼备饮料及有医药功效的双重功能生态保健饮品。
Description
技术领域
本发明属于一种功能性茶制品的制备技术领域，具体涉及一种以花生为主要原料的生物型饮料。
背景技术
花生被人们誉为“植物肉”，含油量高达50％，品质优良，气味清香。花生果具有很高的营养价值，内含丰富的脂肪和蛋白质。据测定花生果内脂肪含量为44％-45％，蛋白质含量为24-36％，含糖量为20％左右。花生中还含有丰富的维生素B2.PP、A、D、E，钙和铁等。并含有硫胺素、核黄素、尼克酸等多种维生素。矿物质含量也很丰富，特别是含有人体必须的氨基酸，有促进脑细胞发育，增强记忆的功能。
现代科技的研究，花生中的维生素K有止血作用。花生红衣的止血作用比花生更高出50倍，对多种出血性疾病都有良好的止血功效。
花生含有维生素E和一定量的锌，能增强记忆，抗老化，延缓脑功能衰退，滋润皮肤。
花生含有的维生素C有降低胆固醇的作用，有助于防治动脉硬化、高血压和冠心病。
花生中的微量元素硒和另一种生物活性物质白藜芦醇可以防治肿瘤类疾病，同时也是降低血小板聚集，预防和治疗动脉粥样硬化、心脑血管疾病的化学预防剂。
花生还有扶正补虚、悦脾和胃、润肺化痰、滋养调气、利水消肿、止血生乳、清咽止疟的作用。
花生花生作为老百姓喜爱的传统食品之一，自古以来就有“长生果”的美誉。民谚道：“常吃花生能养生”，研究发现，其具有一定的药用价值和保健功能。
(1)降低胆固醇：花生油中含有大量的亚油酸，这种物质可使人体内胆固醇分解为胆汁酸排出体外，避免胆固醇在体内沉积，减少因胆固醇在人体中超过正常值而引发多种心脑血管疾病的发生率。
(2)延缓人体衰老：花生中的锌元素含量普遍高于其他油料作物。锌能促进儿童大脑发育，有增强大脑的记忆功能，可激活中老年人脑细胞，有效地延缓人体过早衰老，具有抗老化作用。
(3)促进儿童骨骼发育：花生含钙量丰富，可以促进儿童骨骼发育，并有防止老年人骨骼退行性病变发生。花生中含有丰富的脂肪油和蛋白质，对产后乳汁不足者有养血通乳作用。
(4)预防肿瘤：花生、花生油中含有一种生物活性很强的天然多酚类物质——白藜芦醇。它是肿瘤疾病的天然化学预防剂，同时还能降低血小板聚集，预防和治疗动脉粥样硬化、心脑血管疾病。而白藜芦醇被列为最有效的抗衰老物质之一。而富含白藜芦醇的花生、花生油等相关花生制品将会对饮食与健康发挥更大的作用。
(5)凝血止血：花生衣中含有油脂和多种维生素，并含有使凝血时间缩短的物质，能对抗纤维蛋白的溶解，有促进骨髓制造血小板的功能，对多种出血性疾病，不但有止血的作用，而且对原发病有一定的治疗作用，对人体造血功能有益。
(6)滋血通乳：花生中含丰富的脂肪油和蛋白质，对产后乳汁不足者，有滋补气血，养血通乳作用。
(7)促进发育：花生中钙含量极高，钙是构成人体骨骼的主要成分，故多食花生，可以促进人体的生长发育。
(8)增强记忆：花生富含卵磷脂和脑磷脂，它是神经系统所需要的重要物质，能延缓脑功能衰退，抑制血小板凝集，防止脑血栓形成。
目前，花生除了榨油及供人食用外，还加工成为花生奶、花生饮品等。
发明内容
本发明的目的就是提供全新的一种以花生为主要原料的生物型饮料。具体包括：以花生粒为主要原料制备花生浆汁，然后再以花生浆汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的花生红茶菌生物型饮料。
所述的红茶菌是以茶水、糖为原料，经醋酸菌、酵母菌和乳酸菌等多种微生物共同发酵而成的。其中，红茶菌菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。红茶菌还富含维生素C、维生素B等营养素，并含有多种对人体有益的微生物，因此能调节人体生理机能，促进新陈代谢，帮助消化，防止动脉硬化，抗癌，养生强身，成为一种盛行全世界的养生保健饮料。
红茶菌在中国流传应用已有150余年的历史，近些年国内外医学界应用红茶菌的实践表明，红茶菌能治疗多种慢性疾病，如高血压、动脉硬化、冠心病、糖尿病、便秘、痔疮、肥胖症、斑秃、白发、白内障、风湿性关节炎、胃炎、痢疾、贫血、核黄素缺乏等。
根据营养分析，红茶菌饮料主要营养成分及相应的功能如下：
(1)多糖、茶多酚、低聚异麦芽糖、茶碱：提高人体免疫力，增强自身抵抗力；调节血脂，调节血糖；促进双歧杆菌生长，减少肠道腐败物质和致癌物质；增加T-淋巴细胞和B-淋巴细胞的数量，提高机体的防御能力。
(2)醋酸、乳酸、柠檬酸：清理肠胃，帮助消化，防治便秘，提高维生素的稳定性，预防有害病菌、病毒入侵，预防感冒。
(3)咖啡因：提高大脑活力，消除疲劳，振作精神。
(4)红茶菌中含有三种对人体有益的益生菌：酵母菌，醋酸菌和乳酸菌。对人体可起到特殊的保健作用。
(5)清理肠胃，消毒解毒，通畅大便，杀灭有害病菌，增加有益菌落，适用于急慢性胃炎，肠炎，便秘，顽固性便秘消除，顽固性腹泻，痢疾等痊愈。
(6)调理肠胃，食欲不振这增加饮食，饭量大增，营养不良者可恢复健康，特别是可使城乡最常见最难治的胃溃疡，十二指肠胃溃疡，胃下垂等胃病痊愈，反胃，呕吐，反酸水等症状消失。
(7)现代医学证明，醋酸具有消除疲劳、增强食欲、帮助消化、防治高血压和动脉硬化的作用，还具有一定的抗肿瘤、防肥胖，使钙易于被人体吸收、保持骨骼的柔韧以及润肌嫩肤的作用。
(8)肝脏障碍排除，急慢性肝炎、肝硬化痊愈。许多人认为红茶菌的解毒抗癌功能因子之一是葡萄糖醛酸，它是人体肝脏中最主要的解毒物质之一。
(9)红茶菌中存在的葡萄糖二酸1，4内酯可使肝素、透明质酸、硫酸粘多糖以及葡萄糖醛酸的破坏大大减少，帮助身体更有效地排出毒素，防癌抗癌，并缓解关节炎、痛风、气喘和相关组织功能下降所引起的其它不适。
(10)痔疮软化消失，更年期功能障碍减少。红茶菌中的葡萄糖酸能与重金属结合形成水溶性复合物，帮助人体排出有害的重金属元素。有研究表明新的红茶菌饮用者尿中的重金属含量增加。
本发明是通过以下技术方案来实现的：
一种以花生为主要原料的生物型饮料，技术方案中在于：以花生粒为主要原料制备花生浆汁，然后再以花生浆汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的花生红茶菌生物型饮料。
1、所述的花生浆汁制备方法如下：
(1)原料选择：采集无变质、无杂质、无虫害的花生粒为原料；
(2)原料组成及配比：花生粒1份、清水10～15份；
(3)混料：将上述花生粒和清水混合在一起，并浸泡10～12个小时；
(4)打浆：将浸泡过10～12个小时的花生粒和清水一起打成原料浆液；
(5)煮制：把上述原料浆液放置于加热容器，然后加热至原料浆液沸腾并持续5～6分钟得花生浆汁。
2、所述的花生红茶菌生物型饮料制备方法如下：
(1)原料组成及配比：花生浆汁100份、红糖11份、红茶菌种2份；
(2)发酵：将上述花生浆汁、红糖、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将花生浆汁发酵至溶液的PH为3.5～4.5而得成品花生红茶菌生物型饮料。
本发明既有如下优点：
1、本发明所提出的花生红茶菌生物型饮料其制备方法不但构思新颖，而且配方简单，加工工艺亦很简单，容易实施。
2、实施本发明所用的主要原料——花生，该原料不但资源丰富，而且容易组织，同时价格低廉。重要的是花生营养丰富，还具有众多的保健功效，是一种绿色天然的养生佳品。
3、制备本发明的菌源——红茶菌，该菌种具有培育方法简单、菌种形成周期短、生产成本低廉、菌种质量稳定等有点；红茶菌中主要含有三种对人体特别有益的益生菌：酵母菌、醋酸菌和乳酸菌，对人体可起到特殊的保健作用；同时，由于红茶菌是用茶叶制备的茶液作为培养基，所以菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。因此，红茶菌不但富含有多种对人体有益的微生物，还含有多种营养物质，能调节人体生理机能、促进新陈代谢、帮助消化、防止动脉硬化、抗癌、养生强身等。
4、通过实施本发明，将花生和红茶菌有机结合起来，所组合起来的营养物质更加丰富；花生和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显。其综合效果远超单纯花生制成的各种食品及传统的红茶菌饮料。
5、通过实施本发明，所制备出来的花生红茶菌生物型饮料口感酸甜适口，适口性非常好，是一种兼备饮料及有医药功效的双重功能生态保健饮品。
6、通过实施本发明，制备而成的花生红茶菌生物型饮料成本非常低，但由于该饮料营养丰富、保健效果好、物美价廉，适用人群极为广泛，所以市场前景非常好。
7、本发明制作出来的产品形态理想，产品很好地保留了花生原有的营养和功能成分，容易消化吸收，增强了特殊功能；改变了目前市场上花生加工产品稀少的现状，解决了花生的产后出路，并带动花生相关产业的发展，形成新的经济增长点，具有巨大的经济效益和社会效益。
具体实施方式
下面结合实施例对本发明的方法进一步说明。
一种以花生为主要原料的生物型饮料，技术方案中在于：以花生粒为主要原料制备花生浆汁，然后再以花生浆汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的花生红茶菌生物型饮料。
具体实施方式如下：
1、制备花生浆汁：
(1)原料选择：采集无变质、无杂质、无虫害的花生粒为原料；
(2)原料组成及配比：花生粒1份、清水10～15份；
(3)混料：将上述花生粒和清水混合在一起，并浸泡10～12个小时；
(4)打浆：将浸泡过10～12个小时的花生粒和清水一起打成原料浆液；
(5)煮制：把上述原料浆液放置于加热容器，然后加热至原料浆液沸腾并持续5～6分钟得花生浆汁。
2、制备花生红茶菌生物型饮料：
(1)原料组成及配比：花生浆汁100份、红糖11份、红茶菌种2份；
(2)发酵：将上述花生浆汁、红糖、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将花生浆汁发酵至溶液的PH为3.5～4.5而得成品花生红茶菌生物型饮料。
Claims (1)
1.一种以花生为主要原料的生物型饮料，其特征在于：以花生粒为主要原料制备花生浆汁，然后再以花生浆汁为培养基，以红糖为碳源，用红茶菌为菌源，制备出一种新型特色的花生红茶菌生物型饮料；
所述的花生浆汁制备方法如下：
(1)原料选择：采集无变质、无杂质、无虫害的花生粒为原料；
(2)原料组成及配比：花生粒1份、清水10～15份；
(3)混料：将上述花生粒和清水混合在一起，并浸泡10～12个小时；
(4)打浆：将浸泡过10～12个小时的花生粒和清水一起打成原料浆液；
(5)煮制：把上述原料浆液放置于加热容器，然后加热至原料浆液沸腾并持续5～6分钟得花生浆汁；
所述的花生红茶菌生物型饮料制备方法如下：
(1)原料组成及配比：花生浆汁100份、红糖11份、红茶菌种2份；
(2)发酵：将上述花生浆汁、红糖、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将花生浆汁发酵至溶液的pH为3.5～4.5而得成品花生红茶菌生物型饮料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410624518.2A CN104287046B (zh) | 2014-11-07 | 2014-11-07 | 一种以花生为主要原料的生物型饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410624518.2A CN104287046B (zh) | 2014-11-07 | 2014-11-07 | 一种以花生为主要原料的生物型饮料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104287046A CN104287046A (zh) | 2015-01-21 |
| CN104287046B true CN104287046B (zh) | 2016-04-20 |
Family
ID=52307214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410624518.2A Active CN104287046B (zh) | 2014-11-07 | 2014-11-07 | 一种以花生为主要原料的生物型饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104287046B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106071569A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以花生为载体培育虫草生物型饮品 |
| CN106071568A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以花生为载体培育灵芝生物型饮品 |
| CN106071570A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以花生为载体培育桑黄生物型饮品 |
| CN107691704A (zh) * | 2017-10-18 | 2018-02-16 | 中国科学院昆明植物研究所 | 一种红茶菌饮料及其制备方法 |
| CN109105886A (zh) * | 2018-09-12 | 2019-01-01 | 深圳市淳睿贸易有限公司 | 一种花生红衣酵素及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110903A (zh) * | 1994-04-28 | 1995-11-01 | 沈荣光 | 红茶菌保健食品、饮料及其加工方法 |
| CN1279042A (zh) * | 1999-07-06 | 2001-01-10 | 纪壮 | 乳酸型蛋白保健饮料及加工工艺 |
| CN1253108C (zh) * | 2004-10-11 | 2006-04-26 | 王�义 | 红茶菌饮料的生产方法 |
| CN1977675A (zh) * | 2005-12-08 | 2007-06-13 | 赵伟 | 一种乳酸饮料的制备方法 |
| CN101455430B (zh) * | 2008-12-29 | 2012-12-05 | 陕西天宝大豆食品技术研究所 | 花生肽乳酸菌饮料及其制备方法 |
| CN101843346A (zh) * | 2010-03-23 | 2010-09-29 | 福建师范大学 | 发酵法制备红茶菌果汁饮料的方法 |
| CN102578560A (zh) * | 2011-01-05 | 2012-07-18 | 甄宗伦 | 蜂蜜发酵饮料 |
| CN102389134B (zh) * | 2011-11-07 | 2013-04-24 | 钟麒 | 一种红茶菌复合发酵饮料及制备方法 |
| CN102599594A (zh) * | 2012-03-16 | 2012-07-25 | 王顺林 | 绿茶菌养生保健饮料及其制作方法 |
-
2014
- 2014-11-07 CN CN201410624518.2A patent/CN104287046B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104287046A (zh) | 2015-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104305427A (zh) | 葡萄红茶菌饮料 | |
| CN104287046B (zh) | 一种以花生为主要原料的生物型饮料 | |
| CN104304560A (zh) | 一种甜茶红茶菌 | |
| CN104382164A (zh) | 一种灵芝红茶菌 | |
| CN104304577A (zh) | 一种以金花茶为载体的生物型饮料及其制备方法 | |
| CN104287040A (zh) | 以百香果为原料制备生物型饮料 | |
| CN104336719A (zh) | 一种枸杞红茶菌饮料 | |
| CN104304578A (zh) | 一种火龙果菌茶 | |
| CN104351887A (zh) | 一种桑葚茶菌 | |
| CN104273271A (zh) | 一种荷花红茶菌饮料 | |
| CN104273628A (zh) | 以薏米为原料的生物饮料及其制备方法 | |
| CN104382129A (zh) | 一种甜玉米红茶菌饮品 | |
| CN104351900A (zh) | 一种以糯米为原料的生物型饮料及其制备方法 | |
| CN104273613A (zh) | 一种芒果茶菌饮料 | |
| CN104287039A (zh) | 一种以糙米为原料的生物饮料及其制备方法 | |
| CN104273612A (zh) | 一种甘蔗生物型饮品 | |
| CN104304589A (zh) | 一种铁皮石斛茶菌 | |
| CN104287044A (zh) | 一种猕猴桃红茶菌饮品 | |
| CN104286281A (zh) | 一种西瓜红茶菌饮料 | |
| CN104286280A (zh) | 一种木瓜红茶菌饮品 | |
| CN104304561A (zh) | 一种桑黄菌丝红茶菌饮料 | |
| CN104287045A (zh) | 一种大清枣茶菌饮品 | |
| CN104305429A (zh) | 一种发酵型黄秋葵茶饮料 | |
| CN104432367A (zh) | 一种以墨米为原料的生物型饮料及其制备方法 | |
| CN108497064B (zh) | 一种搅拌型铁皮石斛水牛酸乳及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 533400 the Guangxi Zhuang Autonomous Region Baise Longlin county science and Technology Bureau Patentee after: He Han Address before: 531500 the Guangxi Zhuang Autonomous Region Baise Tiandong County Dongning road he Heng Xiang No. 253 Patentee before: He Han |
|
| CP02 | Change in the address of a patent holder | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180913 Address after: 362199 Room 401, 50 Jianan Road, Huian Town, Fujian Province, 401 Co-patentee after: Liu Bin Patentee after: Zhuang Mingchuan Address before: 533400 the Guangxi Zhuang Autonomous Region Baise long Lin county science and Technology Bureau Patentee before: He Han |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190211 Address after: 530007 Tianyu Huating Building 1001, 1002, 29 Kede West Road, Nanning City, Guangxi Zhuang Autonomous Region Patentee after: Guangxi Huikang biological Polytron Technologies Inc Address before: 362199 Room 401, 50 Jianan Road, Huian Town, Fujian Province, 401 Co-patentee before: Liu Bin Patentee before: Zhuang Mingchuan |
|
| TR01 | Transfer of patent right |